Hepatitis E Virus Infection—Immune Responses to an Underestimated Global Threat

Infection with the hepatitis E virus (HEV) is one of the main ubiquitous causes for developing an acute hepatitis. Moreover, chronification plays a predominant role in immunocompromised patients such as transplant recipients with more frequent severe courses. Unfortunately, besides reduction of immu...

Full description

Bibliographic Details
Main Authors: Paul Kupke, Jens M. Werner
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/10/9/2281
_version_ 1797519938017034240
author Paul Kupke
Jens M. Werner
author_facet Paul Kupke
Jens M. Werner
author_sort Paul Kupke
collection DOAJ
description Infection with the hepatitis E virus (HEV) is one of the main ubiquitous causes for developing an acute hepatitis. Moreover, chronification plays a predominant role in immunocompromised patients such as transplant recipients with more frequent severe courses. Unfortunately, besides reduction of immunosuppression and off-label use of ribavirin or pegylated interferon alfa, there is currently no specific anti-viral treatment to prevent disease progression. So far, research on involved immune mechanisms induced by HEV is limited. It is very difficult to collect clinical samples especially from the early phase of infection since this is often asymptomatic. Nevertheless, it is certain that the outcome of HEV-infected patients correlates with the strength of the proceeding immune response. Several lymphoid cells have been identified in contributing either to disease progression or achieving sustained virologic response. In particular, a sufficient immune control by both CD4<sup>+</sup> and CD8<sup>+</sup> T cells is necessary to prevent chronic viral replication. Especially the mechanisms underlying fulminant courses are poorly understood. However, liver biopsies indicate the involvement of cytotoxic T cells in liver damage. In this review, we aimed to highlight different parts of the lymphoid immune response against HEV and point out questions that remain unanswered regarding this underestimated global threat.
first_indexed 2024-03-10T07:49:52Z
format Article
id doaj.art-f7e8c9da4f6544e2a4fb2baf489e88ce
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T07:49:52Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-f7e8c9da4f6544e2a4fb2baf489e88ce2023-11-22T12:23:39ZengMDPI AGCells2073-44092021-09-01109228110.3390/cells10092281Hepatitis E Virus Infection—Immune Responses to an Underestimated Global ThreatPaul Kupke0Jens M. Werner1Department of Surgery, University Hospital Regensburg, 93053 Regensburg, GermanyDepartment of Surgery, University Hospital Regensburg, 93053 Regensburg, GermanyInfection with the hepatitis E virus (HEV) is one of the main ubiquitous causes for developing an acute hepatitis. Moreover, chronification plays a predominant role in immunocompromised patients such as transplant recipients with more frequent severe courses. Unfortunately, besides reduction of immunosuppression and off-label use of ribavirin or pegylated interferon alfa, there is currently no specific anti-viral treatment to prevent disease progression. So far, research on involved immune mechanisms induced by HEV is limited. It is very difficult to collect clinical samples especially from the early phase of infection since this is often asymptomatic. Nevertheless, it is certain that the outcome of HEV-infected patients correlates with the strength of the proceeding immune response. Several lymphoid cells have been identified in contributing either to disease progression or achieving sustained virologic response. In particular, a sufficient immune control by both CD4<sup>+</sup> and CD8<sup>+</sup> T cells is necessary to prevent chronic viral replication. Especially the mechanisms underlying fulminant courses are poorly understood. However, liver biopsies indicate the involvement of cytotoxic T cells in liver damage. In this review, we aimed to highlight different parts of the lymphoid immune response against HEV and point out questions that remain unanswered regarding this underestimated global threat.https://www.mdpi.com/2073-4409/10/9/2281hepatitis E virussolid organ transplantationinnate lymphoid cellsnatural killer cellsnatural killer T cellsT cells
spellingShingle Paul Kupke
Jens M. Werner
Hepatitis E Virus Infection—Immune Responses to an Underestimated Global Threat
Cells
hepatitis E virus
solid organ transplantation
innate lymphoid cells
natural killer cells
natural killer T cells
T cells
title Hepatitis E Virus Infection—Immune Responses to an Underestimated Global Threat
title_full Hepatitis E Virus Infection—Immune Responses to an Underestimated Global Threat
title_fullStr Hepatitis E Virus Infection—Immune Responses to an Underestimated Global Threat
title_full_unstemmed Hepatitis E Virus Infection—Immune Responses to an Underestimated Global Threat
title_short Hepatitis E Virus Infection—Immune Responses to an Underestimated Global Threat
title_sort hepatitis e virus infection immune responses to an underestimated global threat
topic hepatitis E virus
solid organ transplantation
innate lymphoid cells
natural killer cells
natural killer T cells
T cells
url https://www.mdpi.com/2073-4409/10/9/2281
work_keys_str_mv AT paulkupke hepatitisevirusinfectionimmuneresponsestoanunderestimatedglobalthreat
AT jensmwerner hepatitisevirusinfectionimmuneresponsestoanunderestimatedglobalthreat